Dashboard
Manage Tickers

MCKMCKESSON CORP

NYSE mckesson.com


$ 524.72 $ 5.91 (1.14 %)    

Friday, 19-Apr-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 414.30 $ -8.89 (-2.1 %)
DIA $ 379.83 $ 1.99 (0.53 %)
SPY $ 494.89 $ -4.54 (-0.91 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.67 (0.3 %)
$ 518.81
$ 518.25
$ 0.00 x 0
$ 0.00 x 0
$ 517.77 - $ 525.83
$ 350.91 - $ 543.00
631,442
na
69.16B
$ 0.68
$ 23.07
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-07-2024 12-31-2023 10-Q
2 11-01-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-K
5 02-02-2023 12-31-2022 10-Q
6 11-02-2022 09-30-2022 10-Q
7 08-03-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-K
9 02-02-2022 12-31-2021 10-Q
10 11-01-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-K
13 02-02-2021 12-31-2020 10-Q
14 11-03-2020 09-30-2020 10-Q
15 08-03-2020 06-30-2020 10-Q
16 05-22-2020 03-31-2020 10-K
17 02-04-2020 12-31-2019 10-Q
18 10-30-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-K
21 01-31-2019 12-31-2018 10-Q
22 10-25-2018 09-30-2018 10-Q
23 07-26-2018 06-30-2018 10-Q
24 05-24-2018 03-31-2018 10-K
25 02-01-2018 12-31-2017 10-Q
26 10-27-2017 09-30-2017 10-Q
27 07-27-2017 06-30-2017 10-Q
28 05-22-2017 03-31-2017 10-K
29 01-26-2017 12-31-2016 10-Q
30 10-27-2016 09-30-2016 10-Q
31 07-27-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-K
33 01-27-2016 12-31-2015 10-Q
34 10-29-2015 09-30-2015 10-Q
35 07-29-2015 06-30-2015 10-Q
36 05-12-2015 03-31-2015 10-K
37 02-05-2015 12-31-2014 10-Q
38 10-28-2014 09-30-2014 10-Q
39 07-31-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jim-cramer-is-willing-to-let-this-pharma-stock-catch-fire-advises-not-to-sell-mckesson
Jim Cramer Is 'Willing To Let This Pharma ...
04/19/2024 12:46:13

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

morgan-stanley-maintains-overweight-on-mckesson-raises-price-target-to-548
Morgan Stanley Maintains Overweight on McK...
04/15/2024 16:40:06

Morgan Stanley analyst Erin Wright maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $522 to ...

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-500-today
If You Invested $100 In This Stock 5 Years...
04/10/2024 21:30:38

argus-research-maintains-buy-on-mckesson-raises-price-target-to-570
Argus Research Maintains Buy on McKesson, ...
04/10/2024 15:23:34

Argus Research analyst David Toung maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $510 to $570.

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-3200-today
If You Invested $1000 In This Stock 10 Yea...
04/03/2024 17:00:25

peering-into-mckessons-recent-short-interest
Peering Into McKesson's Recent Short Interest
03/28/2024 14:15:11

rite-aid-forges-path-to-financial-recovery-with-major-settlement-report
Rite Aid Forges Path To Financial Recovery...
03/27/2024 09:54:55

Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters repor...

mccormick-reaffirms-fy24-sales-growth-outlook-of-2---0-adj-eps-of-280---285-vs-283-est
McCormick Reaffirms FY24 Sales Growth Outl...
03/26/2024 10:35:20

100-invested-in-this-stock-5-years-ago-would-be-worth-400-today
$100 Invested In This Stock 5 Years Ago Wo...
03/18/2024 16:00:35

which-stocks-will-dominate-the-future-of-tech-ubs-shares-its-top-picks-in-ai-healthtech-greentech-and-fintech
Which Stocks Will Dominate The Future Of T...
03/18/2024 07:14:12

In a recent report, global wealth manager UBS has identified the sectors that are likely to drive the next wave of technologica...

ubs-maintains-buy-on-mckesson-raises-price-target-to-620
UBS Maintains Buy on McKesson, Raises Pric...
03/06/2024 17:43:50

UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $575 to $620.

how-is-the-market-feeling-about-mckesson
How Is The Market Feeling About McKesson?
02/27/2024 13:45:23

if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-13000-today
If You Invested $1000 In This Stock 15 Yea...
02/26/2024 17:30:19

leerink-partners-initiates-coverage-on-mckesson-with-outperform-rating-announces-price-target-of-600
Leerink Partners Initiates Coverage On McK...
02/26/2024 13:45:46

Leerink Partners analyst Michael Cherny initiates coverage on McKesson (NYSE:MCK) with a Outperform rating and announces Pri...

us-federal-trade-commission-investigates-drug-shortages-amid-allegations-of-market-manipulation
US Federal Trade Commission Investigates D...
02/14/2024 18:25:53

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scru...

mizuho-maintains-neutral-on-mckesson-raises-price-target-to-505-report-released-on-8th-february-2024
Mizuho Maintains Neutral on McKesson, Rais...
02/09/2024 15:51:40

Mizuho analyst Ann Hynes maintains McKesson (NYSE:MCK) with a Neutral and raises the price target from $450 to $505.

medical-supplies-focused-mckesson-shares-fall-on-q3-earnings-performance-analyst-says-street-wanted-more
Medical Supplies-Focused McKesson Shares F...
02/08/2024 19:29:59

McKesson beats expectations with Q3 2024 sales of $80.9 billion, up 15%. U.S. Pharmaceutical Segment thrives, adjusted EPS at $...

citigroup-maintains-buy-on-mckesson-raises-price-target-to-575
Citigroup Maintains Buy on McKesson, Raise...
02/08/2024 16:20:10

Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $530 to $575.

if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-3900-today
If You Invested $1000 In This Stock 5 Year...
02/08/2024 14:30:19

mckesson-sees-fy24-adj-eps-2725-2765-vs-2732-est
McKesson Sees FY24 Adj. EPS $27.25-$27.65 ...
02/07/2024 21:10:02

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)